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Table 1
12 month 24 m 36 m 48 m 60 m 72 m
MVA (group A); Cm2 1,60 1,64 1,67 1,59 1,54 1,52
MVA (group B) 1,64 1,56 1,54 1,64 1,51 1,47
PAPs (Group A); mmHg 35 32 36 38 34 37
PAPs (Group B) 30 30 30 31 33 31,5
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMConclusions: Our analysis could suggest that PMB might be non-inferior to surgical
commissurotomy presenting with good post procedural outcomes and similar clinical
results. Therefore further larger clinical randomized studies are warranted.
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Background: OBJETIVE:assess the long-term clinical, echocardiographic and he-
modynamics effects of percutaneous mitral balloon valvuloplasty (PMV) on
patients(pts)with pulmonary hypertension(PHT).
Methods: PMV was performed in 157 consecutive pts. 47 (29,9%) had PHT deﬁned
as resting pulmonary artery systolic pressure (PAPs) > 50 mmHg at baseline (group
A), and 110 controls pts(70,1%) (group B). Pts were clinical and echocardiographicaly
evaluated immediately after procedure 6 months after and once per year thereafter.
Following endpoints were considered: restenosis(RS),mitral valve replacement
(MVR) or MBV requirement, or cardiovascular death. A logistic regression model
was adjusted to determine independent predictors for outcome. A value of p < 0.05
was considered signiﬁcant.
Results: Median follow-up was 48 months (Q25-75: 24-84). Group A pts aged
43,7 12 years; 89,3% (42 pts) were female; 23,4% pts had atrial ﬁbrillation (AF).
Median ES was 7(Q25-75: 5-9).No diferences on baseline characteristics, successJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Vasculachievement, RS and follow up symptoms between Groups were found. PMV
inmediate success was 76.6% in Group A and 80% in Group B (P¼NS).MVA
increased from 0,90 cm2 to 1,75 cm2. PAPs fell from 57,5 mmhg to 35 mmHg in
Group A and from 38 mmhg to 30 mmHg in Group B. Success was associated with
ES < 8 (p¼0.01) both in group A and B. Long term outcomes are shown in table 1.
There were 3 in hospital deaths and 3 deaths during follow-up. 10 pts required newPMV; 6 p RVM. RS at 60 months follow-up was associated with ES > 8 in both
groups, A (p¼ 0,03) B (p¼ 0,02).
Conclusions: PMV is a safe and effective technique for treating patients with mitral
stenosis and PHT. Despite a gradual MVA decrease, most patients remain asymp-
tomatic and PAPs values were stable in the long term follow up.Vascular Access and Intervention - Transradial
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Background: Percutaneous coronary intervention (PCI) by the transradial approach
(TRA) is increasing adopted in most countries with the advantage of fewer vascular
complications compared with the transfemoral approach (TFA). Women are associ-
ated with higher risk of bleeding and access site complications undergoing PCI. So we
performed this study to compare the effect of TRA vs. TFA in women patients.
Methods: From July,2006 to Aug,2011, 4755 women patients who have undergone
PCI with stent implantation were included in the analysis. The primary endpoint
was deﬁned as in-hospital net adverse clinical events (NACE), which was a composite
of all-cause death, myocardial infarction (MI), target vessel revascularization
(TVR), stroke and major bleeding. The secondary endpoint was deﬁned as major
adverse cardiovascular events (MACE) which included all-cause death, MI and TVR.
Propensity score (PS) matching was performed to minimize the baseline disparity.
Results: Among 4755 women patients, 3801 (80%) patients were in the TRA group,
and 954 (20%) were in the TFA group. 563 pairs matched after PS calculating. In
the PS-matched patients, the rates of in-hospital NACE (3.6% vs. 5.5%, p¼0.114), in-
hospital MACE (2.0% vs. 2.1%, p¼0.833) and 1 year MACE (5.3% vs. 5.5%,
p¼0.895) were similar between TRA and TFA, but major bleeding (1.6% vs. 3.6%,
p¼0.036) and access site complications (2.0% vs. 7.5%, p< 0.001) were both lower in
the TRA group than in the TFA group.
Conclusions: TRA did not reduce the in-hospital and 1 year adverse clinical outcomes
compared with TFA in the PS-matched women patients, but TRA was associated with
fewer access site complications and major bleeding.
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